181 related articles for article (PubMed ID: 33104848)
1. Nanotechnology improves the therapeutic efficacy of gemcitabine against a human hepatocellular carcinoma cell line and minimizes its in vivo side effects.
El-Sheikh SMA; Khairy MH; Osama E; Metwally MMM; Galal AAA
Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):631-643. PubMed ID: 33104848
[TBL] [Abstract][Full Text] [Related]
2. Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment.
Yuan YG; Peng QL; Gurunathan S
Int J Nanomedicine; 2017; 12():6487-6502. PubMed ID: 28919750
[TBL] [Abstract][Full Text] [Related]
3. Quercetin induces apoptosis and enhances gemcitabine therapeutic efficacy against gemcitabine-resistant cancer cells.
Liu ZJ; Xu W; Han J; Liu QY; Gao LF; Wang XH; Li XL
Anticancer Drugs; 2020 Aug; 31(7):684-692. PubMed ID: 32282368
[TBL] [Abstract][Full Text] [Related]
4. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V
Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103
[TBL] [Abstract][Full Text] [Related]
5. Shrimp shells extracted chitin in silver nanoparticle synthesis: Expanding its prophecy towards anticancer activity in human hepatocellular carcinoma HepG2 cells.
Vijayakumar M; Priya K; Ilavenil S; Janani B; Vedarethinam V; Ramesh T; Arasu MV; Al-Dhabi NA; Kim YO; Kim HJ
Int J Biol Macromol; 2020 Dec; 165(Pt A):1402-1409. PubMed ID: 33045301
[TBL] [Abstract][Full Text] [Related]
6. Raptinal silver nanoparticles: new therapeutic advances in hepatocellular carcinoma mouse model.
Taha H; Elfar N; Haffez H; Hassan ZA
Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):279-289. PubMed ID: 32945892
[TBL] [Abstract][Full Text] [Related]
7. Silver Nanoparticles Exhibit the Dose-Dependent Anti-Proliferative Effect against Human Squamous Carcinoma Cells Attenuated in the Presence of Berberine.
Dziedzic A; Kubina R; Bułdak RJ; Skonieczna M; Cholewa K
Molecules; 2016 Mar; 21(3):365. PubMed ID: 26999092
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Characterization of Folic Acid Conjugated Gemcitabine Tethered Silver Nanoparticles (FA-GEM-AgNPs) for Targeted Delivery.
Karuppaiah A; Rajan R; Hariharan S; Balasubramaniam DK; Gregory M; Sankar V
Curr Pharm Des; 2020; 26(26):3141-3146. PubMed ID: 32175835
[TBL] [Abstract][Full Text] [Related]
9. Could Cisplatin Loading on Biosynthesized Silver Nanoparticles Improve Its Therapeutic Efficacy on Human Prostate Cancer Cell Line and Reduce Its In Vivo Nephrotoxic Effects?
El-Sheikh SMA; Edrees N; El-Sayed H; Khamis T; Arisha AH; Metwally MMM; Eleiwa NZ; Galal AAA
Biol Trace Elem Res; 2022 Feb; 200(2):582-590. PubMed ID: 33759109
[TBL] [Abstract][Full Text] [Related]
10. Suppressing growth, migration, and invasion of human hepatocellular carcinoma HepG2 cells by Catharanthus roseus‑silver nanoparticles.
Azhar NA; Ghozali SZ; Abu Bakar SA; Lim V; Ahmad NH
Toxicol In Vitro; 2020 Sep; 67():104910. PubMed ID: 32526345
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Cytotoxicity of Biomolecules Loaded Metallic Silver Nanoparticles Against Human Liver (HepG2) and Prostate (PC3) Cancer Cell Lines.
Prasannaraj G; Sahi SV; Ravikumar S; Venkatachalam P
J Nanosci Nanotechnol; 2016 May; 16(5):4948-59. PubMed ID: 27483851
[TBL] [Abstract][Full Text] [Related]
12. Development of Liposomal Gemcitabine with High Drug Loading Capacity.
Tamam H; Park J; Gadalla HH; Masters AR; Abdel-Aleem JA; Abdelrahman SI; Abdelrahman AA; Lyle LT; Yeo Y
Mol Pharm; 2019 Jul; 16(7):2858-2871. PubMed ID: 31136710
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine.
Dubey RD; Alam N; Saneja A; Khare V; Kumar A; Vaidh S; Mahajan G; Sharma PR; Singh SK; Mondhe DM; Gupta PN
Int J Pharm; 2015 Aug; 492(1-2):80-91. PubMed ID: 26165611
[TBL] [Abstract][Full Text] [Related]
14. UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy.
Lin L; Fan Y; Gao F; Jin L; Li D; Sun W; Li F; Qin P; Shi Q; Shi X; Du L
Theranostics; 2018; 8(7):1923-1939. PubMed ID: 29556365
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy.
Devulapally R; Foygel K; Sekar TV; Willmann JK; Paulmurugan R
ACS Appl Mater Interfaces; 2016 Dec; 8(49):33412-33422. PubMed ID: 27960411
[TBL] [Abstract][Full Text] [Related]
16. Long-circulating and liver-targeted nanoassemblies of cyclic phosphoryl N-dodecanoyl gemcitabine for the treatment of hepatocellular carcinoma.
Du L; Zhang B; Lei Y; Wang S; Jin Y
Biomed Pharmacother; 2016 Apr; 79():208-14. PubMed ID: 27044830
[TBL] [Abstract][Full Text] [Related]
17. Chitosan-mediated synthesis of biogenic silver nanoparticles (AgNPs), nanoparticle characterisation and in vitro assessment of anticancer activity in human hepatocellular carcinoma HepG2 cells.
Priya K; Vijayakumar M; Janani B
Int J Biol Macromol; 2020 Apr; 149():844-852. PubMed ID: 32027896
[TBL] [Abstract][Full Text] [Related]
18. Green-Synthesized Silver and Selenium Nanoparticles Using Berberine: A Comparative Assessment of In Vitro Anticancer Potential on Human Hepatocellular Carcinoma Cell Line (HepG2).
Khaled AM; Othman MS; Obeidat ST; Aleid GM; Aboelnaga SM; Fehaid A; Hathout HMR; Bakkar AA; Moneim AEA; El-Garawani IM; Morsi DS
Cells; 2024 Feb; 13(3):. PubMed ID: 38334679
[TBL] [Abstract][Full Text] [Related]
19. Chlorambucil gemcitabine conjugate nanomedicine for cancer therapy.
Fan M; Liang X; Li Z; Wang H; Yang D; Shi B
Eur J Pharm Sci; 2015 Nov; 79():20-6. PubMed ID: 26342774
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle modulation by a multitargeted antifolate, LY231514, increases the cytotoxicity and antitumor activity of gemcitabine in HT29 colon carcinoma.
Tonkinson JL; Worzalla JF; Teng CH; Mendelsohn LG
Cancer Res; 1999 Aug; 59(15):3671-6. PubMed ID: 10446980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
